Flormotridaz[18F]

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameFlormotridaz[18F]
Drug Alias Name18F-FMPPFlormotridaz F-18[18F]Fmpp-2[18F]FMPPXTR-004
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[4] 
Mechanisms of ActionRadionuclide imaging enhancers
TargetsNADH dehydrogenase
Therapy Area/IndicationsContrast agentsCoronary Artery DiseaseCoronary Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeijing Xiantong International Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeijing Xiantong International Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsContrast agentsCoronary Artery DiseaseCoronary Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A